Amphastar Pharmaceuticals (AMPH) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Amphastar Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $1.7M of AMPH stock on the open market.
Get emailed when insiders cluster-buy stocks like AMPH
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AMPH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $764K | 5 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $945K | 7 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Amphastar Pharmaceuticals, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $1.7M. 4 of 12 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
AMPH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 6, 2026 | +3.3% | None | +2.7%S&P +0.5% | +11.5% |
| May 7, 2026 | +12.7% | None | -20.5%S&P +0.5% | +3.9% |
| Feb 26, 2026 | -2.1% | None | -27.7%S&P -1.0% | -6.0% |
| Nov 6, 2025 | +4.3% | Sold $13K | -5.1%S&P -1.0% | +11.4% |
| Aug 7, 2025 | -2.5% | None | +14.4%S&P +0.7% | +23.6% |
| May 7, 2025 | +1.6% | None | +3.3%S&P +1.1% | +5.4% |
| Feb 27, 2025 | -3.1% | None | -8.9%S&P -0.1% | +0.0% |
| Nov 6, 2024 | +1.5% | None | -10.6%S&P +3.3% | -5.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 23SEC | William J PetersCFO | Sell Plan | 4,139168,707 held (−2%) | $25.00 | $103K | +6.5% | — |
| Sep 17SEC | Rong ZhouSenior Evp, Production Center | Sell | 10,000169,203 held (−6%) | $23.94 | $239K | +11.2% | — |
| Sep 3SEC | Rong ZhouSenior Evp, Production Center | Sell | 3,187169,203 held (−2%) | $23.63 | $75K | +12.7% | — |
| Aug 12SEC | Richard K PrinsDirector | Sell | 7,97329,625 held (−21%) | $20.30 | $162K | +31.1% | — |
| Aug 11SEC | William J PetersCFO | Sell Plan | 8,180172,846 held (−5%) | $22.48 | $184K | +18.4% | — |
| Dec 18SEC | Rong ZhouSenior Evp, Production Center | Sell | 9,787138,043 held (−7%) | $26.20 | $256K | +1.6% | — |
| Dec 15SEC | Floyd F. PetersenDirector | Sell | 2,42671,368 held (−3%) | $25.92 | $63K | +2.7% | — |
| Dec 15SEC | Floyd F. PetersenDirector | Sell | 1,73773,794 held (−2%) | $25.69 | $45K | +3.6% | — |
| Nov 25SEC | Richard K PrinsDirector | Sell | 4,17935,183 held (−11%) | $27.10 | $113K | -1.8% | — |
| Nov 17SEC | Floyd F. PetersenDirector | Sell | 16,67975,531 held (−18%) | $26.49 | $442K | +0.5% | — |
| Nov 5SEC | Floyd F. PetersenDirector | Sell Plan | 50075,531 held (−1%) | $25.27 | $13K | +5.3% | — |
| Oct 2SEC | Floyd F. PetersenDirector | Sell Plan | 50076,031 held (−1%) | $27.20 | $14K | -2.1% | — |
Insiders at Amphastar Pharmaceuticals, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Floyd F. PetersenDirector | — | $576K | Dec 15, 2025 | — |
| Rong ZhouSenior Evp, Production Center | — | $571K | Sep 17, 2026 | — |
| William J PetersCFO | — | $287K | Sep 23, 2026 | — |
| Richard K PrinsDirector | — | $275K | Aug 12, 2026 | — |
AMPH stock: common questions
Are Amphastar Pharmaceuticals, Inc. insiders buying AMPH stock?
In the past 12 months, 0 insiders reported open-market purchases of AMPH worth $0.
Are Amphastar Pharmaceuticals, Inc. insiders selling AMPH stock?
4 insiders reported sales worth $1.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AMPH's 52-week range?
Over the past year AMPH has traded between $16.87 and $29.40. It last closed at $26.62 on Oct 9, 2026.